Autor(es):
Cibula, David ; Raspollini, Maria Rosaria ; Planchamp, François ; Centeno, Carlos ; Chargari, Cyrus ; Felix, Ana ; Fischerová, Daniela ; Jahnn-Kuch, Daniela ; Joly, Florence ; Kohler, Christhardt ; Lax, Sigurd ; Lorusso, Domenica ; Mahantshetty, Umesh ; Mathevet, Patrice ; Naik, Raj ; Nout, Remi A. ; Oaknin, Ana ; Peccatori, Fedro ; Persson, Jan ; Querleu, Denis ; Bernabé, Sandra Rubio ; Schmid, Maximilian P. ; Stepanyan, Artem ; Svintsitskyi, Valentyn ; Tamussino, Karl ; Zapardiel, Ignacio ; Lindegaard, Jacob
Data: 2023
Identificador Persistente: http://hdl.handle.net/10362/155689
Origem: Repositório Institucional da UNL
Assunto(s): Cervical cancer; Pathology; Radiation; Surgical oncology; Pathology and Forensic Medicine; Molecular Biology; Cell Biology; SDG 3 - Good Health and Well-being
Descrição
Funding Information: Open access publishing supported by the National Technical Library in Prague. Funding Information: The authors thank ESGO, ESTRO, and ESP for their support. The authors also thank the 155 international reviewers (physicians and patient representatives, see Appendix 2 ) for their valuable comments and suggestions. The authors thank the ESGO office, especially Kamila Macku, Tereza Cicakova, and Kateřina Šibravová, provided invaluable logistical and administrative support throughout the process. Publisher Copyright: © 2023, ESGO, ESTRO, ESP.
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer. To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives. These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
